|
|
Competitive Threats
January 2012 | By Fuld & Company
“The scenario analysis process does not aim to predict the future…Instead, the process seeks to outline a range of possibilities.”
The scenario analysis (alternative futuring) methodology was created by British Intelligence and further developed by Royal/Dutch Shell Oil in the 1960s. As many other companies adopted the process over the years, it has been further refined and is now a widely used technique to plan for possible future worlds and to mitigate risk associated with those worlds.
|
|
How to Envision Alternative Futures for the Biopharmaceutical and Healthcare Markets
2010 | By Fuld & Company
“The scenario analysis process does not aim to predict the future…Instead, the process seeks to outline a range of possibilities.”
The scenario analysis (alternative futuring) methodology was created by British Intelligence and further developed by Royal/Dutch Shell Oil in the 1960s. As many other companies adopted the process over the years, it has been further refined and is now a widely used technique to plan for possible future worlds and to mitigate risk associated with those worlds.
|
|
|
Over The Line Ethics Survey – A Report on the Boundaries of Gathering Competitor Information
December 2010 | By Leonard Fuld
Companies do not want their employees stealing information and breaking the law. They also do not want those same employees even giving the appearance of impropriety by crossing an ethical boundary. This, too, could land a company in court. The lesson this survey teaches is that many companies have codified a set of rules for information collection, but have failed to teach or express those rules to their employees. It is this specific weakness and its implications this survey covers.
|
|
Generic Medical Devices Are Closer Than They Appear
November 2010 | By Fuld & Company
What if a significant portion of a $200 million segment of the medical device market were to go generic? Generic Medical Device (GMD) launched a Universal Sling System™ for female stress urinary incontenence (SUI), a class II medical device, during the summer of 2009. Market research indicates that 33% of physicians are sensitive to price. There fore those physisicians might consider using a "generic" device rather than a brand.
|